NFDI4DS | UHH-SEMS - Publication Details

Raúl Piedrabuena

ORCID: 0000-0002-2980-5334

Publications

Citations

Views

---

Saved

---

About

Contact & Profiles

A5024208673

Research Areas

Multiple Sclerosis Research Studies
Rheumatoid Arthritis Research and Therapies
Peripheral Neuropathies and Disorders
Fibromyalgia and Chronic Fatigue Syndrome Research
Systemic Lupus Erythematosus Research
Autoimmune and Inflammatory Disorders Research
Long-Term Effects of COVID-19
Systemic Sclerosis and Related Diseases
Health Systems, Economic Evaluations, Quality of Life
Retinal and Optic Conditions
Diphtheria, Corynebacterium, and Tetanus
Chronic Lymphocytic Leukemia Research
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
SARS-CoV-2 and COVID-19 Research
Ocular Diseases and Behçet’s Syndrome
Parkinson's Disease Mechanisms and Treatments
Cerebral Palsy and Movement Disorders
Multiple Myeloma Research and Treatments
Stroke Rehabilitation and Recovery
Prenatal Screening and Diagnostics
Effects of Vibration on Health
Atherosclerosis and Cardiovascular Diseases
Biotechnology and Related Fields
Virology and Viral Diseases
Cardiovascular and Diving-Related Complications

Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno
2024

Helios Salud
2024

Hospital Universitario Austral
2024

Instituto Oncológico de Córdoba
2020-2023

Hospital Privado
2023

Servicio Diabetología Hospital Córdoba
2019

NeuroRx Research (Canada)
2018

Vrije Universiteit Amsterdam
2018

COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America

OPENALEX - Publications

Ricardo Alonso Berenice Silva Orlando Garcea Patricio E. Correa Diaz Giordani Rodrigues dos Passos and 49 more

10.1016/j.msard.2021.102886 article EN other-oa Multiple Sclerosis and Related Disorders 2021-03-07

Cierre percutáneo de defecto complejo del septum interauricular: Implante inusual de dos dispositivos

OPENALEX - Publications

Alejandro Peirone Alejandro Contreras María L. Martínez Raúl Piedrabuena

10.7775/rac.es.v89.i5.20442 article ES Revista Argentina de Cardiología 2025-03-28

Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patients

OPENALEX - Publications

Edgar Carnero Contentti Juan Pablo Pettinicchi Pablo A. López Ricardo Alonso Orlando Garcea and 21 more

10.1016/j.msard.2019.05.024 article EN Multiple Sclerosis and Related Disorders 2019-05-30

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)

OPENALEX - Publications

Juan Ignacio Rojas Ricardo Alonso Orlando Garcea Liliana Patrucco Adriana Carrá and 67 more

10.1007/s10072-019-04230-6 article EN Neurological Sciences 2020-01-20

Consensus recommendations on the management of multiple sclerosis patients in Argentina

OPENALEX - Publications

Edgardo Cristiano Juan Ignacio Rojas Ricardo Alonso Amelia Alvez Pinheiro Elizabeth Alejandra Bacile Bacile and 32 more

10.1016/j.jns.2019.116609 article EN Journal of the Neurological Sciences 2019-12-02

Neuro rehabilitation effectiveness based on virtual reality and tele rehabilitation in people with multiple sclerosis in Argentina: Reavitelem study

OPENALEX - Publications

María Laura Saladino Carla Gualtieri Myriam Scaffa Maya F. Lopatin Eduardo Köhler and 9 more

10.1016/j.msard.2023.104499 article EN Multiple Sclerosis and Related Disorders 2023-01-03

Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies

OPENALEX - Publications

Ricardo Alonso Magdalena Casas Luciana Lazaro Nora Fernández Liguori Cecilia Pita and 29 more

We aimed to determine the proportion of highly active multiple sclerosis patients under high-efficacy therapies (HETs) achieve no evidence disease activity-3 (NEDA-3) at 1 and 2 years, identify factors associated with failing meet activity 3 years.This retrospective cohort study based on Argentina Multiple Sclerosis patient registry (RelevarEM), includes who received HETs.In total, 254 (78.51%) achieved NEDA-3 year 220 (68.12%) 2. Patients years had a shorter duration (p < 0.01) time between...

10.1177/20552173231154712 article EN cc-by-nc Multiple Sclerosis Journal - Experimental Translational and Clinical 2023-01-01

Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina

OPENALEX - Publications

Ricardo Alonso Magdalena Casas Luciana Lazaro Nora Fernández Liguori Cecilia Pita and 28 more

10.1016/j.msard.2023.104935 article EN Multiple Sclerosis and Related Disorders 2023-08-09

Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry

OPENALEX - Publications

María Agustina Piedrabuena Jorge Correale Marcela Fiol Mariano Marrodán Juan Ignacio Rojas and 44 more

10.1016/j.jns.2024.123052 article EN Journal of the Neurological Sciences 2024-05-16

Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina

OPENALEX - Publications

Juan Ignacio Rojas Ricardo Alonso Geraldine Luetic Liliana Patrucco Magdalena Casas and 24 more

Objective The aim was to evaluate patient profiles, effectiveness and safety of cladribine (CLAD) in patients with relapsing-remitting multiple sclerosis Argentina. Methods This a substudy included RelevarEM (MS neuromyelitis optica registry Argentina, NCT03375177). Patients MS who received CLAD tablets were followed up for at least 24 months included. Clinical evaluations every 3 collect information about: a) clinical relapses; b) progression physical disability, evaluated through Expanded...

10.1097/wnf.0000000000000598 article EN Clinical Neuropharmacology 2024-05-22

Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?

OPENALEX - Publications

Geraldine Luetic María Laura Menichini Cárlos Vrech Agustín Pappolla Liliana Patrucco and 63 more

10.1016/j.msard.2021.103401 article EN Multiple Sclerosis and Related Disorders 2021-11-17

Absence of latitudinal gradient in oligoclonal bands prevalence in Argentina

OPENALEX - Publications

Laura Negrotto Mariano Marrodán Marcela Fiol María I. Gaitán María Célica Ysrraelit and 69 more

10.1016/j.msard.2020.102582 article EN Multiple Sclerosis and Related Disorders 2020-10-13

Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis

OPENALEX - Publications

Raúl Piedrabuena Marina C Bittar

10.1016/j.msard.2021.103420 article EN Multiple Sclerosis and Related Disorders 2021-11-29

Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEM

OPENALEX - Publications

Gisela Zanga Carla Portinari Barber Josefina Ibañez Tomas Brolese Lucia and 49 more

The discontinuation of disease-modifying therapies (DMTs) in multiple sclerosis (MS) is commonly seen real-world settings due to several factors.The aim this study describe the frequency disease activity after DMTs MS patients included Argentinean and NMOSD registry.Patients with relapsing remitting (RRMS) active secondary progressive (SPMS) were based on following criteria: they discontinued treatment for more than 6 months, had been treated a DMT ≥2 years, at least months follow-up...

10.1080/01616412.2022.2124792 article EN Neurological Research 2022-10-02

Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM

OPENALEX - Publications

Matías Kohler Eduardo Köhler Cárlos Vrech Agustín Pappolla Jimena Míguez and 68 more

10.1016/j.jocn.2021.05.047 article EN Journal of Clinical Neuroscience 2021-06-01

Guía de práctica clínica: tratamiento agudo de las enfermedades inflamatorio-desmielinizantes del sistema nervioso central: esclerosis múltiple, espectro de la neuromielitis óptica, encefalomielitis diseminada aguda, enfermedades asociadas a anticuerpos antiglicoproteína de la membrana del oligodendrocito, mielitis aguda y neuritis óptica. Elaborada por el Grupo de Trabajo de Enfermedades Desmielinizantes. Sociedad Neurológica Argentina

OPENALEX - Publications

Javier Hryb Darío Tavolini Fátima Pagani Cassara Berenice Silva Juan Ignacio Rojas and 39 more

10.1016/j.neuarg.2023.02.003 article ES Neurología Argentina 2023-04-01

Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile

OPENALEX - Publications

María Célica Ysrraelit Alejandro Caride Vladimiro Sinay Mario Rivera Kindel Mario Javier Halfón and 3 more

ABSTRACT Background: The real-world effectiveness of natalizumab in people with relapsing multiple sclerosis (PwRMS) Argentina and Chile has not been reported. Objective: To evaluate the treatment PwRMS Chile, clinical practice. Methods: We conducted a multicenter retrospective observational study. reviewed medical records who had treated for at least one year, without any interruption MS that lasted more than 12 weeks. analyzed changes annualized relapse rate (ARR), Expanded Disability...

10.1590/0004-282x-anp-2020-0303 article EN cc-by Arquivos de Neuro-Psiquiatria 2021-05-01

Consenso sobre la identificación y seguimiento de la esclerosis múltiple secundaria progresiva en Argentina

OPENALEX - Publications

Edgardo Cristiano Liliana Patrucco María Célica Ysrraelit Ricardo Alonso María Eugenia Balbuena and 29 more

The identification, diagnosis, follow-up, and treatment of patients with secondary progressive multiple sclerosis (SPMS) show significant differences between health care professionals in Argentina.To provide consensus recommendations on the management SPMS Argentina to optimize patient care.A panel expert neurologists from dedicated diagnosis gathered during 2019 2020 carry out a recommendation Argentina. To achieve consensus, methodology 'formal consensus-RAND/UCLA method' was used....

10.33588/rn.7201.2020379 article ES Revista de Neurología 2020-12-31

Guía de práctica clínica: tratamiento sintomático de esclerosis múltiple. Grupo de Trabajo de Enfermedades Desmielinizantes. Sociedad Neurológica Argentina

OPENALEX - Publications

Andrés Barboza Vladimiro Sinay Gisela Zanga Ricardo Alonso Berenice Silva and 28 more

10.1016/j.neuarg.2022.04.002 article ES Neurología Argentina 2022-04-01

Estrategias de manejo de terapias de alta eficacia para esclerosis múltiple en la práctica clínica

OPENALEX - Publications

Andrés Barboza Jorge Correale Ricardo Alonso Marcos Burgos Fernando Cáceres and 13 more

10.1016/j.neuarg.2023.03.001 article ES Neurología Argentina 2023-04-01

Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study

OPENALEX - Publications

Norma Deri Andrés Barboza Cárlos Vrech Roberto Rey Marcos Burgos and 9 more

10.1016/j.msard.2023.105421 article EN Multiple Sclerosis and Related Disorders 2023-12-31

Coming Soon ...